Ivan Bo Nielsen

Ivan Bo Nielsen serves as Chief Physician at Aalborg University Hospital's Anesthesia and Intensive Care Unit with formal affiliation to Aalborg University's Faculty of Health Sciences. His dual clinical-academic role positions him at the intersection of critical care medicine and translational research in palliative oncology.

Research focuses on cognitive impacts of cannabinoid therapies in advanced cancer, specifically low-dose dronabinol's effects on working memory and neurocognitive function during palliative care. This work bridges pharmacological intervention with quality-of-life outcomes, addressing critical gaps in symptom management for terminal cancer patients. Key domains include palliative pharmacology, cognitive neuroscience in oncology, and symptom-focused clinical trials.

His 2023 intervention study demonstrates growing scholarly influence, evidenced by Scopus citations and significant social media amplification across 51 X accounts and 23 Mendeley readers. The research trajectory indicates deepening specialization in cannabinoid-based palliative solutions with potential for broader clinical implementation.

No formal advising roles or grant histories are documented in available sources, though his active research output suggests ongoing institutional support for palliative care innovation within Aalborg's medical ecosystem.